SCHEMBL9126691

SCHEMBL9126691

Nc1ccc(Nc2ccc(N=C3C=CC(=Nc4ccccc4)C=C3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.59
▸ ALDH1A1 P00352 6/20 0.59
▸ HTT P42858 4/20 0.59
▸ L3MBTL1 Q9Y468 4/20 0.59
▸ CYP3A4 P08684 2/20 0.59
▸ ALOX12 P18054 2/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ CYP2C9 P11712 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ MEN1 O00255 5/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ PKM P14618 1/20 0.48
▸ TDP1 Q9NUW8 5/20 0.44
▸ HSD17B10 Q99714 4/20 0.44
▸ TSHR P16473 2/20 0.44
▸ ALOX15 P16050 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ HPGD P15428 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28230071 1.00 MAPT (0.59) MAPTALDH1A1HTTL3MBTL1CYP3A4
SCHEMBL15489199 0.96 MAPT (0.64) MAPTALDH1A1HTTL3MBTL1CYP3A4
SCHEMBL19427098 0.96 MAPT (0.64) MAPTALDH1A1HTTL3MBTL1CYP3A4
SCHEMBL12747007 0.93 MAPT (0.50) MAPTALDH1A1HTTL3MBTL1CYP3A4
SCHEMBL13663471 0.91 ALDH1A1 (0.52) MAPTALDH1A1HTTL3MBTL1CYP3A4
SCHEMBL13663464 0.89 ALDH1A1 (0.55) MAPTALDH1A1HTTL3MBTL1CYP3A4
SCHEMBL13663469 0.89 ALDH1A1 (0.55) MAPTALDH1A1HTTL3MBTL1CYP3A4
SCHEMBL13663466 0.89 ALDH1A1 (0.55) MAPTALDH1A1HTTL3MBTL1CYP3A4
SCHEMBL13663468 0.89 ALDH1A1 (0.55) MAPTALDH1A1HTTL3MBTL1CYP3A4
SCHEMBL13663465 0.87 ALDH1A1 (0.57) MAPTALDH1A1HTTL3MBTL1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11793893-B2 Compounds comprising conductive oligomers, materials formed therefrom, and methods of making and using same THE PENN STATE RESEARCH FOUNDATION (PA) 2023-10-24 — — US disclosed
US-20220209174-A1 DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF LG DISPLAY CO., LTD. (KR) 2022-06-30 — — US disclosed
US-20190231909-A1 Compounds Comprising Conductive Oligomers, Materials Formed Therefrom, and Methods of Making and Using Same THE PENN STATE RESEARCH FOUNDATION (US) 2019-08-01 — — US disclosed
US-20120211702-A1 Electrically Conducting Polymer And Copolymer Compositions, Methods For Making Same And Applications Therefor THE OHIO STATE UNIVERSITY (US) 2012-08-23 — — US disclosed
US-20120211702-A1 Electrically Conducting Polymer And Copolymer Compositions, Methods For Making Same And Applications Therefor THE OHIO STATE UNIVERSITY (US) 2012-08-23 — — US disclosed
US-7875210-B2 Epoxy adhesive resin from bisphenol A unit, a bisphenol F unit, a diglycidyl ether unit and/or a novolac unit and an electrically-conductive organoaniline filler COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2011-01-25 — — US disclosed
US-7875210-B2 Epoxy adhesive resin from bisphenol A unit, a bisphenol F unit, a diglycidyl ether unit and/or a novolac unit and an electrically-conductive organoaniline filler COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2011-01-25 — — US disclosed
US-20080251766-A1 ADHESIVE COMPOSITE MATERIAL WITH CONTROLLED RESISTIVITY COMMISSARIAT A L'ENERGIE ATOMIQUE 2008-10-16 — — US disclosed
US-20080251766-A1 ADHESIVE COMPOSITE MATERIAL WITH CONTROLLED RESISTIVITY COMMISSARIAT A L'ENERGIE ATOMIQUE 2008-10-16 — — US disclosed
US-5420237-A Electroconductive polymers ALLIEDSIGNAL INC. (US) 1995-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11793893-B2 Compounds comprising conductive oligomers, materials formed therefrom, and methods of making and using same PICALM, ILK, GJB2 MAPT 1051/4885ALDH1A1 2647/4885HTT 1516/4885
US-20190231909-A1 Compounds Comprising Conductive Oligomers, Materials Formed Therefrom, and Methods of Making and Using Same PICALM, ILK, GJB2 MAPT 1051/4885ALDH1A1 2647/4885HTT 1516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback